How GLP-1 Agonists Improve Overall Survival in Breast Cancer Care

CancerNetwork·Jun 19

This story is reported by CancerNetwork. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Could GLP-1 receptor agonists improve breast cancer outcomes for patients with obesity or type 2 diabetes?

Oncology Central·May 13

2

GLP-1 Receptor Agonists May Reduce Metastatic Progression in Certain Obesity-Related Cancers

The ASCO Post·Jun 25

3

GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival

Oncology Nursing News·Jun 3

4

GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer

Pharmacy Times – Pharmacy Practice News and Expert Insights·May 13

5

GLP-1 RA Exposure After Diagnosis Could Lead to Reduced Progression, Improved Survival in Multiple Malignancies

ASCO Daily News·May 23

6

What You Need to Know About GLP-1s and Breast Cancer Care

Breast Cancer Research Foundation | BCRF·Dec 29

7

Beyond Weight Loss: GLP-1s Show Promise in Breast Cancer

Medscape·Dec 18

8

Association of GLP-1RA Therapy with Reduced Metastasis in Solid Tumors

Physician's Weekly·Jun 24